Skip to content

Improved ultrasound-guided percutaneous microwave ablation in the treatment of thyroid nodule standardized research

Improved ultrasound-guided percutaneous microwave ablation in the treatment of thyroid nodule standardized research

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011334
Enrollment
Unknown
Registered
2017-05-08
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid nodule

Interventions

The treatment group:Implementation of the improved thyroid nodules under microwave ablation guided by ultrasound
The control group:Simple application of the improved thyroid nodules under microwave ablation guided by ultrasound

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. comply with thyroid nodules Western diagnostic criteria and gall disease in medical diagnostic criteria; 2. aged 18 to 78 years; 3. imaging or aspiration cytology or coarse - needle biopsy is diagnosed with thyroid benign nodules ultrasound tips nodules calcium and/or blood flow signal rich; 4. nodules convex of beautiful or on postoperative beautiful have a higher requester; 5. refuse surgery requirements minimally invasive surgery; 6. because of thyroid nodules over anxiety and requirements minimally invasive surgery.

Exclusion criteria

Exclusion criteria: 1. has clear diagnosed with cancer person; 2. merge have important organ serious damage mental illness coagulation and thyroid function obvious abnormal; 3. pregnancy; 4. accordping to researchers judgment have lower into the group may or make into the group complicate the other a history of such as work environment often change easy to cause lost the situation; 5. participating in other drug clinical research subjects or just the end of other drug trials insufficient 3 months.

Design outcomes

Primary

MeasureTime frame
Thyroid nodule change situation;Thyroid function change;Syndrome in patients with change;security;

Countries

China

Contacts

Public ContactWang Xiaoping

Shanghai Municipal Hospital of Traditional Chinese Medicine

578924160@qq.com+86 18116070860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026